United States · FDA National Drug Code directory
Ezetimibe and Simvastatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-509_ca1a42e2-f129-462a-8e87-a034da71862b
- Product NDC
- 67877-509
- Form
- TABLET
- Composition / generic term
- Ezetimibe and Simvastatin
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171224
- Source listing expiry
- 20261231
Source-listed ingredients
- EZETIMIBE — 10 mg/1
- SIMVASTATIN — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (67877-509-05) · 67877-509-05
- 30 TABLET in 1 BOTTLE (67877-509-30) · 67877-509-30
- 5 BLISTER PACK in 1 CARTON (67877-509-37) / 10 TABLET in 1 BLISTER PACK (67877-509-33) · 67877-509-37
- 90 TABLET in 1 BOTTLE (67877-509-90) · 67877-509-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →